Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

78.15
Delayed Data
As of Aug 23
 -0.11 / -0.14%
Today’s Change
64.18
Today|||52-Week Range
86.72
+6.25%
Year-to-Date

Today’s Trading

Previous close78.26
Today’s open78.20
Day’s range78.05 - 78.52
Volume1,801,475
Average volume (3 months)3,849,123
Market cap$86.2B
Dividend yield2.66%
Data as of 4:01pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+18.16%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+6.33%
P/E ratio33.8
Price/Sales3.68
Price/Book6.15

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.07-0.14%
NVONovo Nordisk-0.78-1.69%
BMYBristol-Myers Squibb+0.20+0.35%
GSKGlaxoSmithKline+0.19+0.49%
Data as of 4:03pm ET, 08/23/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts